|
| 38039941 | Exploratory 5-year follow-up study of retinol, tocopherols, and carotenoids in multiple sclerosis. | Mult Scler Relat Disord | 2024 |
| 36306062 | Evaluation of supervised machine learning algorithms in predicting the poor anticoagulation control and stable weekly doses of warfarin. | Int J Clin Pharm | 2023 |
| 37215748 | Lithium's effects on therapeutic targets and MRI biomarkers in Parkinson's disease: A pilot clinical trial. | IBRO Neurosci Rep | 2023 |
| 37151181 | Antioxidant defense enzymes in multiple sclerosis: A 5-year follow-up study. | Eur J Neurol | 2023 |
| 37079261 | Metabolomic profiles in relapsing-remitting and progressive multiple sclerosis compared to healthy controls: a five-year follow-up study. | Metabolomics | 2023 |
| 37361716 | Proteomics and relationship with axonal pathology in multiple sclerosis: 5-year diffusion tensor imaging study. | Brain Commun | 2023 |
| 37394678 | Repurposing Artificial Intelligence Tools for Disease Modeling: Case Study of Face Recognition Deficits in Neurodegenerative Diseases. | Clin Pharmacol Ther | 2023 |
| 36403378 | Cholesterol pathway biomarkers are associated with neuropsychological measures in multiple sclerosis. | Mult Scler Relat Disord | 2023 |
| 36460305 | Generative adversarial networks for modelling clinical biomarker profiles with race/ethnicity. | Br J Clin Pharmacol | 2023 |
| 36565395 | Generative models for age, race/ethnicity, and disease state dependence of physiological determinants of drug dosing. | J Pharmacokinet Pharmacodyn | 2023 |
| 34611796 | Machine learning-guided, big data-enabled, biomarker-based systems pharmacology: modeling the stochasticity of natural history and disease progression. | J Pharmacokinet Pharmacodyn | 2022 |
| 35474598 | Lower cerebral arterial blood flow is associated with greater serum neurofilament light chain levels in multiple sclerosis patients. | Eur J Neurol | 2022 |
| 35671670 | Plasma 24-hydroxycholesterol is associated with narrower common carotid artery and greater flow velocities in relapsing multiple sclerosis. | Mult Scler Relat Disord | 2022 |
| 35398271 | The role of cholesterol metabolism in multiple sclerosis: From molecular pathophysiology to radiological and clinical disease activity. | Autoimmun Rev | 2022 |
| 35964555 | Effect of ocrelizumab on leptomeningeal inflammation and humoral response to Epstein-Barr virus in multiple sclerosis. A pilot study. | Mult Scler Relat Disord | 2022 |
| 36136071 | Dysregulated Sulfide Metabolism in Multiple Sclerosis: Serum and Vascular Endothelial Inflammatory Responses. | Pathophysiology | 2022 |
| 33634893 | Machine learning in pharmacometrics: Opportunities and challenges. | Br J Clin Pharmacol | 2022 |
| 32255388 | Neurofilament levels are associated with blood-brain barrier integrity, lymphocyte extravasation, and risk factors following the first demyelinating event in multiple sclerosis. | Mult Scler | 2021 |
| 33595444 | Patient Empowerment and the Exclusion of Dietary Intervention Studies. Comment on "Diet and Multiple Sclerosis: Scoping Review of Web-Based Recommendations". | Interact J Med Res | 2021 |
| 33677412 | The cholesterol autoxidation products, 7-ketocholesterol and 7β-hydroxycholesterol are associated with serum neurofilaments in multiple sclerosis. | Mult Scler Relat Disord | 2021 |
| 34197237 | Hypertension and hypertension severity in Hispanics/Latinx with MS. | Mult Scler | 2021 |
| 30507270 | Fatigue at enrollment predicts EDSS worsening in the New York State Multiple Sclerosis Consortium. | Mult Scler | 2020 |
| 31863460 | Generalized Pharmacometric Modeling, a Novel Paradigm for Integrating Machine Learning Algorithms: A Case Study of Metabolomic Biomarkers. | Clin Pharmacol Ther | 2020 |
| 31661187 | Clinical FDG-PET Findings in Patients with Temporal Lobe Epilepsy: Concordance with EEG and MRI. | J Neuroimaging | 2020 |
| 32012815 | Infections, Vaccines and Autoimmunity: A Multiple Sclerosis Perspective. | Vaccines (Basel) | 2020 |
| 31768628 | A multimodal approach to assess the validity of atrophied T2-lesion volume as an MRI marker of disease progression in multiple sclerosis. | J Neurol | 2020 |
| 33178104 | Relationships Among Circulating Levels of Hemostasis Inhibitors, Chemokines, Adhesion Molecules, and MRI Characteristics in Multiple Sclerosis. | Front Neurol | 2020 |
| 32947088 | High density lipoprotein cholesterol and apolipoprotein A-I are associated with greater cerebral perfusion in multiple sclerosis. | J Neurol Sci | 2020 |
| 32772303 | Application of Brunauer-Emmett-Teller (BET) theory and the Guggenheim-Anderson-de Boer (GAB) equation for concentration-dependent, non-saturable cell-cell interaction dose-responses. | J Pharmacokinet Pharmacodyn | 2020 |
| 32883876 | Anacardic acid, interleukin-33, and the quest for remyelination. | Proc Natl Acad Sci U S A | 2020 |
| 32683305 | Apolipoproteins AI and E are associated with neuroaxonal injury to gray matter in multiple sclerosis. | Mult Scler Relat Disord | 2020 |
| 32932824 | Serum Neurofilament Light Chain Levels are Associated with Lower Thalamic Perfusion in Multiple Sclerosis. | Diagnostics (Basel) | 2020 |
| 32758395 | Neuroprotective associations of apolipoproteins A-I and A-II with neurofilament levels in early multiple sclerosis. | J Clin Lipidol | 2020 |
| 32424064 | Serum neurofilament light chain and optical coherence tomography measures in MS: A longitudinal study. | Neurol Neuroimmunol Neuroinflamm | 2020 |
| 31487715 | Lipoprotein(a) Levels Are Associated with the Size of Extracranial Arteries in Multiple Sclerosis. | J Vasc Res | 2020 |
| 30755085 | Higher EBV response is associated with more severe gray matter and lesion pathology in relapsing multiple sclerosis patients: A case-controlled magnetization transfer ratio study. | Mult Scler | 2020 |
| 30641248 | Could high lithium levels in tobacco contribute to reduced risk of Parkinson's disease in smokers? | J Neurol Sci | 2019 |
| 31211794 | Lipid profile is associated with decreased fatigue in individuals with progressive multiple sclerosis following a diet-based intervention: Results from a pilot study. | PLoS One | 2019 |
| 31525628 | Teriflunomide's effect on humoral response to Epstein-Barr virus and development of cortical gray matter pathology in multiple sclerosis. | Mult Scler Relat Disord | 2019 |
| 31437387 | Serum neurofilament light chain levels associations with gray matter pathology: a 5-year longitudinal study. | Ann Clin Transl Neurol | 2019 |
| 31307953 | High-density lipoprotein cholesterol is associated with multiple sclerosis fatigue: AÂ fatigue-metabolism nexus? | J Clin Lipidol | 2019 |
| 31304367 | Evaluating digital medicine ingestion data from seriously mentally ill patients with a Bayesian Hybrid Model. | NPJ Digit Med | 2019 |
| 31116081 | Lifestyle-based modifiable risk factors in multiple sclerosis: review of experimental and clinical findings. | Neurodegener Dis Manag | 2019 |
| 31085627 | Oxysterols and apolipoproteins in multiple sclerosis: a 5 year follow-up study. | J Lipid Res | 2019 |
| 31000816 | Epidemiology and treatment of multiple sclerosis in elderly populations. | Nat Rev Neurol | 2019 |
| 31082401 | Neurolymphatic biomarkers of brain endothelial inflammatory activation: Implications for multiple sclerosis diagnosis. | Life Sci | 2019 |
| 30758665 | Dietary and lifestyle factors in multiple sclerosis progression: results from a 5-year longitudinal MRI study. | J Neurol | 2019 |
| 31049035 | Marijuana Use by Patients with Multiple Sclerosis. | Int J MS Care | 2019 |
| 30597511 | Are Plasma Levels of Vascular Adhesion Protein-1 Associated Both with Cerebral Microbleeds in Multiple Sclerosis and Intracerebral Haemorrhages in Stroke? | Thromb Haemost | 2019 |
| 30539801 | The role of Epstein-Barr virus in multiple sclerosis: from molecular pathophysiology to <i>in vivo</i> imaging. | Neural Regen Res | 2019 |